Funds raised through initial public offerings (IPO) in Hong Kong have exceeded HK$76 billion (US$9.7 billion) so far in 2025, the city\u2019s finance chief has said, following the biggest listing of the year by a mainland Chinese battery manufacturer last week.<\/p>\n
Financial Secretary Paul Chan Mo-po also said on Sunday that deepening ties with the mainland was key for Hong Kong\u2019s long-term development, despite negative evaluations from some ratings agencies, as he expressed confidence in the city\u2019s markets to withstand external shocks.<\/p>\n
Writing on his weekly blog, Chan described the city\u2019s IPO market as \u201cbustling\u201d after it welcomed the world\u2019s largest offering so far this year.<\/p>\n
Battery giant Contemporary Amperex Technology (CATL), which supplies the likes of Tesla and Volkswagen, saw its shares jump by more than 16 per cent in its listing<\/a> last week, raising HK$41 billion. This propelled Hong Kong back to the top spot in global fundraising.In another significant listing, Jiangsu Hengrui Pharmaceuticals, one of the mainland\u2019s largest drug manufacturers, raised HK$9.89 billion in its trading debut<\/a> on Friday, with shares soaring by 25 per cent.<\/p>\n \u201cSo far this year, the amount of funds raised from new share offerings in Hong Kong has exceeded HK$76 billion, an increase of more than seven times over the same period last year, and has reached nearly 90 per cent of the total amount of funds raised for all of [2024],\u201d Chan said.<\/p>\n Chan added that the government would continue to safeguard the security of Hong Kong\u2019s financial markets amid what he described as a \u201ccomplex and ever-changing\u201d geopolitical and economic landscape.<\/p>\n","protected":false},"excerpt":{"rendered":"Funds raised through initial public offerings (IPO) in Hong Kong have exceeded HK$76 billion (US$9.7 billion) so far…\n","protected":false},"author":2,"featured_media":130248,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3091],"tags":[51,57389,57387,57386,57390,29884,57384,3749,53159,23702,10831,57388,57385,2441,35397,16,15],"class_list":{"0":"post-130247","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-markets","8":"tag-business","9":"tag-catl","10":"tag-contemporary-amperex-technology","11":"tag-finance-chief","12":"tag-financial-secretary-paul-chan-mo-po","13":"tag-fitch-ratings","14":"tag-hk76-billion","15":"tag-hong-kong","16":"tag-hong-kong-ipo-market","17":"tag-initial-public-offerings","18":"tag-ipo","19":"tag-jiangsu-hengrui-pharmaceuticals","20":"tag-mainland","21":"tag-markets","22":"tag-moodys","23":"tag-uk","24":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114567666246261595","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/130247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=130247"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/130247\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/130248"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=130247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=130247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=130247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}